PATENT CLAIM ANALYSIS

Application Number: 16044259
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "486000"]

Abstract:
An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a C max  to C min  ratio of less than 200 and a lag time less than 0.2

Claim (Index 5):
The composition of  claim 4 , comprising from about 5 wt % to about 30 wt % of risperidone base.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.44186
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15422626', '14701173', '13790930', '11535398', '10701939']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.694380839249873
- 35 USC 102 Novelty (BERT): 0.5366344872270363
- Combined Prediction Score: 0.6786062040475894
- Mean Citation Score: 317.634532
- Max Citation Score: 360.80765
- Similarity Product: 261.1710303296775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test